by Jody Ranck | September 09, 2022
AI and Trust in Healthcare: A New Report from Chilmark Research
Industry-wide cooperation will be needed to foster trust in the rapidly growing healthcare AI sector. Chilmark’s latest report tackles this and more.
Tag Archive: FDA
by Jody Ranck | September 09, 2022
Industry-wide cooperation will be needed to foster trust in the rapidly growing healthcare AI sector. Chilmark’s latest report tackles this and more.
by Jody Ranck | June 06, 2022
Mistakes were made in the deployment of artificial intelligence in aircraft, leading to fatal outcomes. How can healthcare avoid similar results?
by John Moore | December 15, 2021
Chilmark’s 2021 predictions were mostly accurate, but could have been more daring. Our outlook on 2022 is forthcoming and will include some tougher calls.
by John Moore | November 29, 2021
Unique circumstances have led to the rise of this evolving sector. Despite plenty of growth potential, the most effective approach remains to be seen.
by Jody Ranck | November 16, 2021
The FDA released a set of principles for the implementation of new technologies, but will it be enough to positively impact current industry practice?
by Jody Ranck | April 12, 2021
Digital twins provide more dynamic models than conventional simulations and will provide valuable tools for precision medicine. Learn more in this deep dive article.
by Chilmark Team | December 18, 2020
Unlike past years when we have written a post evaluating how well our predictions for that year held up, let’s […]
by Jody Ranck | October 15, 2020
While COVID-19 has been dominating the healthcare headlines so far in 2020 there have been a number of recent policy and regulatory decisions bearing on the AI/ML market in healthcare.
Elena Iakovleva · 2 months ago
Fatma Niang · 2 months ago
Jody Ranck · 3 weeks ago